News & Events about Bausch Lomb Corp.
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (Bausch + Lomb), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2022 financial results on Wednesday, Feb. 22, 2023. Bausch + Lomb will host a conference call and live...
Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (Bausch + Lomb or the Company), a leading global eye health company dedicated to helping people see better to live better, has published a company update presentation designed to complement remarks that will be provided by management at 3:00 p.m. PT (6:00...
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (Bausch + Lomb), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national non-profit organization with the vision of curing glaucoma, today announced the U.S. launch of...
Shares of Bausch + Lomb Co. (NYSE:BLCO Get Rating) have been assigned an average recommendation of Moderate Buy from the fourteen ratings firms that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and ten have issued a buy ...
Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year from Business Intelligence Group Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year...